Drug profile · INN
sufentanil citrate
SUFENTANIL CITRATE
sufentanil citrate (SUFENTANIL CITRATE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Drug details — sufentanil citrate
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 2
- Data quality
- 0.84
Quick answer
sufentanil citrate (SUFENTANIL CITRATE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Mu opioid receptor agonist
Primary target: Mu-type opioid receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is sufentanil citrate?
sufentanil citrate (SUFENTANIL CITRATE) is a mu opioid receptor agonist. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for sufentanil citrate?
SUFENTANIL CITRATE is a marketed brand name for sufentanil citrate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of sufentanil citrate?
sufentanil citrate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.